Statera BioPharma (STU:7CB) FCF Margin % : 0.00% (As of Sep. 2022)

View and export this data going back to 2021. Start your Free Trial

What is Statera BioPharma FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Statera BioPharma's Free Cash Flow for the three months ended in Sep. 2022 was €-0.81 Mil. Statera BioPharma's Revenue for the three months ended in Sep. 2022 was €0.00 Mil. Therefore, Statera BioPharma's FCF Margin % for the quarter that ended in Sep. 2022 was 0.00%.

As of today, Statera BioPharma's current FCF Yield % is -24.72%.

The historical rank and industry rank for Statera BioPharma's FCF Margin % or its related term are showing as below:

STU:7CB's FCF Margin % is not ranked ^*
in the Biotechnology industry.
Industry Median: -137.43
* Ranked among companies with meaningful FCF Margin % only.

Statera BioPharma FCF Margin % Historical Data

The historical data trend for Statera BioPharma's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Statera BioPharma FCF Margin % Chart

Statera BioPharma Annual Data

Trend

Dec19

Dec20

Dec21

FCF Margin %

Statera BioPharma Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22
FCF Margin %	Get a 7-Day Free Trial						-	-	-	-	-

Competitive Comparison of Statera BioPharma's FCF Margin %

For the Biotechnology subindustry, Statera BioPharma's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Statera BioPharma's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Statera BioPharma's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Statera BioPharma's FCF Margin % falls into.

Statera BioPharma FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Statera BioPharma's FCF Margin for the fiscal year that ended in Dec. 2021 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-25.113	/	0
	=	%

Statera BioPharma's FCF Margin for the quarter that ended in Sep. 2022 is calculated as

FCF Margin	=	Free Cash Flow (Q: Sep. 2022 )	/	Revenue (Q: Sep. 2022 )
	=	-0.81	/	0
	=	%

Statera BioPharma FCF Margin % Related Terms

Thank you for viewing the detailed overview of Statera BioPharma's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Statera BioPharma (STU:7CB) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Statera BioPharma Inc (STU:7CB) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

4333 Corbett Drive, Suite 1082, Fort Collins, CO, USA, 80525

Website

https://www.staterabiopharma.com

Statera BioPharma Inc is a pre-clinical and clinical biopharmaceutical company developing multiple product candidates to address unmet medical needs for use in diseases involving immune system dysfunction.

Statera BioPharma (STU:7CB) Headlines

No Headlines